This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of specific drugs targeting neurological and psychiatric disorders, such as selective serotonin reuptake inhibitors (SSRIs) and other central nervous system (CNS) agents. Its chiral structure is significant for creating enantiomerically pure compounds, which are crucial for achieving desired biological activity and reducing side effects. Additionally, it may be explored in the development of novel therapeutic agents for conditions like depression, anxiety, and other mood disorders due to its potential interaction with neurotransmitter systems.